Retroperitoneal Laparoscopic Treatment of Adrenal Myelolipoma (Report of 12 Cases)

Yifu YAN,Yi HUANG,Lulin MA
DOI: https://doi.org/10.3969/j.issn.1001-1420.2010.12.005
2010-01-01
Journal of Clinical Urology
Abstract:Objective:To discuss the clinical significance and therapeutic effect of retroperitoneal laparoscopic treatment of adrenal myelolipoma.Methods:We retrospectively analyzed the clinical data of 12 cases of adrenal myelolipoma. The patients range from 33 to 72 years old (average 53 years old).Of the 12 patients,3 cases had tumor on the left,9 on the right.Tumors were incidentally detected in 10 cases,and other 2 cases,were detected because of patients' complains of paroxysmal hypertension and low back pain,respectively.9 cases (including the case suffering from paroxysmal hypertension)had undergone endocrine examinations,and the results all showed normal.The other 3 cases had not undergone endocrine examinations for their typical imaging shows.The diameter of tumors range from 2 cm to 8 cm (average 4.9 cm),the tumor was larger than 3.5 cm in 8 cases,and smaller than 3.5 cm in the other 4 cases.All 12 cases were preoperatively diagnosed of adrenal myelolipoma.Results: Retroperitoneal laparoscopic adrenalectomy was successfully applied in all 12 cases,the operating time was 60-270 min (average 130 min),the blood loss during operation was 10-660 ml (average 116 ml),and there was no complication during the operation.Postoperative pathology confirmed the diagnosis of adrenal myelolipoma in all the 12 cases,and showed associating with adrenal nodal hyperplasia in 2 cases.The postoperation hospitalization was 4-10 d (average 5.6 d).The patients were followed up ranging from 0.5 to 5 years (average 2 years),no recurrent tumor was found.Conclusions:Diagnosis of adrenal myelolipoma can be mostly established by imaging examinations. Retroperitoneal laparoscopic adrenalectomy is safe and effective,and enjoys advantages of little invasion, low bleeding volume,fast postoperative recovery,it can be the main operative treatment of adrenal mylolipoma.
What problem does this paper attempt to address?